CELZ

Creative Medical Technology Holdings, Inc. NASDAQ Listed Nov 6, 2015

Healthcare ·Biotechnology ·US · creativemedicaltechnology.com

$1.21

Mkt Cap $3.1M

52w Low $0.79 7.7% of range 52w High $6.25

50d MA $2.11 200d MA $2.41

P/E (TTM) —

EV/EBITDA —

P/B 0.4x

Debt/Equity 0.0x

ROE -79.8%

P/FCF -0.5x

RSI (14) 33.90

ATR (14) $0.46

Beta 1.99

50d MA $2.11

200d MA $2.41

Avg Volume 6.7M

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

SIC Code

2836

CIK (SEC)

1187953

Phone

480 399 2822

211 East Osborn Road · Phoenix, AZ 85012 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 20, 2026	AMC	-0.37	-0.80	-116.2%	1.84	+3.8%	+1.1%	-2.7%	+3.3%	+5.9%	-0.5%	—
Nov 7, 2025	AMC	-0.48	-0.48	+0.0%	3.02	+5.3%	+8.6%	-2.4%	-6.6%	-5.7%	+11.7%	—
Aug 8, 2025	AMC	-0.63	-0.48	+23.8%	3.33	-3.6%	-12.3%	+5.8%	+4.5%	-5.0%	+1.6%	—
May 9, 2025	AMC	-0.52	-0.83	-59.6%	2.14	-0.9%	-7.5%	+1.0%	+2.0%	-1.0%	+0.0%	—
Mar 14, 2025	AMC	-0.63	-1.12	-77.8%	3.27	-2.8%	-1.8%	-6.9%	+1.3%	-8.3%	+3.6%	—
Nov 8, 2024	AMC	-0.85	-0.75	+11.8%	2.81	-0.4%	+3.2%	-4.8%	-2.5%	-1.1%	+1.5%	—
Aug 9, 2024	AMC	-0.84	-1.11	-32.1%	2.92	+2.1%	+16.8%	+2.9%	-2.8%	+1.5%	+1.2%	—
May 10, 2024	AMC	-1.15	-0.73	+36.5%	4.35	-0.9%	-0.5%	+2.5%	-0.9%	-1.4%	+2.5%	—
Mar 22, 2024	AMC	-1.13	-1.21	-7.1%	5.19	+0.6%	+4.4%	-6.1%	+1.2%	+1.2%	+6.7%	—
Nov 14, 2023	AMC	-0.86	-1.02	-18.6%	4.25	+1.2%	+4.3%	-0.3%	+1.8%	-2.8%	-2.5%	—
Aug 11, 2023	AMC	-0.83	-0.78	+6.0%	5.17	+0.0%	+0.8%	-2.5%	-11.0%	+1.5%	-1.5%	—
May 12, 2023	AMC	-1.00	-0.70	+30.0%	6.60	+3.0%	+0.0%	-5.8%	+6.1%	-10.3%	+4.7%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 25	Roth Capital	Maintains	Buy → Buy	—	$18.30	$21.00	+14.8%	+1.6%	-2.2%	-5.5%	+3.5%	-0.6%

Data updated apr 25, 2026 12:41am · Source: financialmodelingprep.com